Zhifei Biotech announced that the company previously reviewed and approved the share repurchase plan. It plans to use its own or self-raised funds to repurchase A-shares through centralized bidding for share incentives or employee stock ownership plans. The total repurchase capital is not less than 150 million yuan and no more than 300 million yuan. The repurchase price is no more than 18.22 yuan/share, and the repurchase period is within 12 months from the date of review and approval by the board of directors. Recently, the company obtained a special loan commitment letter for stock repurchase issued by the Chongqing branch of the Bank of China. The bank agreed to provide a special loan of no more than 210 million yuan and no more than 70% of the repurchase transaction price. The loan will be used to repurchase the company's shares for a period of no more than 3 years. The specific rights and obligations are subject to the final signed loan contract.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.